Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
The Trivolib Forte 1 Tablet ER is a combination therapy that is used to manage type 2 diabetes mellitus in adults and is classified under anti-diabetic medications. It facilitates the effective regulation of blood sugar levels.
Trivolib Forte 1 Tablet ER is a combination anti-diabetic medication that assists in the management of type 2 diabetes by regulating blood sugar levels. It is a combination of Glimepiride, Metformin, and Voglibose, each of which operates through distinct mechanisms to enhance insulin sensitivity, decrease glucose production, and reduce post-meal blood sugar increases. In conjunction with a balanced diet, consistent exercise, and weight management, it is imperative to take this medication as prescribed and on a regular basis. Nausea, diarrhea, abdominal pain, and low blood sugar are potential adverse effects. If you are pregnant or breastfeeding, or if you have a history of cardiac, liver, or renal disease, it is important to consult your doctor before using this product.
As your body adjusts to the medication, these adverse effects are typically temporary and may improve. Please consult your physician if they continue or become a cause for concern.
1 Strip of 15 Tablet
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Follow your physician's instructions regarding the dosage and duration of Trivolib Forte 1 Tablet ER. Do not chew, pulverize, or split the tablet; swallow it whole. In order to optimize its advantages and mitigate the likelihood of an unsettled stomach, it is recommended that it be consumed with food. Please ensure that you consume it at the same time each day.
Trivolib Forte 1 Tablet ER is a combination of three anti-diabetic agents: Glimepiride, Metformin, and Voglibose. Metformin enhances insulin sensitivity and reduces glucose production in the liver, while Glimepiride increases insulin secretion from the pancreas. Voglibose inhibits enzymes that break down carbohydrates, thereby reducing post-meal blood sugar levels.
Related Warnings
It is hazardous to consume alcohol while taking Trivolib Forte 1 Tablet ER, as it can increase the risk of hypoglycemia (low blood sugar) and potentially result in lactic acidosis.
Trivolib Forte 1 Tablet ER may not be safe for use during pregnancy. Limited human research is available; however, animal studies indicate that the developing infant may be harmed. Before taking this medication, it is important to consult with your physician to evaluate the risks and benefits.
Limited human data indicates that Trivolib Forte 1 Tablet ER may pass into breast milk and impact the infant, suggesting that it is likely hazardous to use during breastfeeding. Be sure to consult with your physician prior to use.
Should your blood sugar level fluctuate between low and high, Trivolib Forte 1 Tablet ER may impede your driving capabilities. If you are experiencing symptoms that impair your reaction time or concentration, it is advisable to refrain from operating a vehicle.
Trivolib Forte 1 Tablet ER is likely to be hazardous for patients with kidney disease, particularly those with moderate to severe conditions. Please consult your physician regarding an alternative treatment regimen.
In patients with liver disease, Trivolib Forte 1 Tablet ER should be administered with caution. It is generally not recommended to use this medication in severe liver disease, and dosage adjustments may be necessary.
1. What should I do if I neglect a dose?
If you forget to take a dose of Trivolib Forte 1 Tablet ER, take it as soon as you remember. If your next scheduled dose is imminent, forego the delayed dose and adhere to your usual regimen. Do not increase the dosage in order to make up for lost time.
2. Is it possible for Trivolib Forte 1 Tablet ER to induce hypoglycemia?
Yes, Trivolib Forte 1 Tablet ER can induce hypoglycemia, particularly when consumed in conjunction with alcohol, exercise, or skipping meals. Always maintain a fast-acting sugar source and be aware of symptoms such as trembling, sweating, and vertigo.
3. Is Trivolib Forte 1 Tablet ER suitable for use during pregnancy?
The safety of Trivolib Forte 1 Tablet ER during pregnancy is dubious. Before utilizing this medication, it is recommended that you consult with your physician for personalized guidance.
4. Is it permissible to operate a motor vehicle while consuming Trivolib Forte 1 Tablet ER?
Your ability to operate a motor vehicle may be compromised by Trivolib Forte 1 Tablet ER, particularly if your blood sugar levels are either too low or too high. If you are experiencing symptoms such as lethargy or vertigo, it is advisable to refrain from operating a vehicle.
5. How should Trivolib Forte 1 Tablet ER be stored?
Trivolib Forte 1 Tablet ER should be stored in its original packaging, with the lid securely closed, and away from pets and children. Adhere to the label's stowage instructions. Properly dispose of any unused medication.
